ArticleFrontiers in immunology2025

Case Report: Spesolimab for pyoderma gangrenosum in an undifferentiated oligoarthritis patient receiving anti-IL-17 therapy.

Weiwei Xin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.